BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bravo D, Hoare A, Soto C, Valenzuela MA, Quest AF. Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects. World J Gastroenterol 2018; 24(28): 3071-3089 [PMID: 30065554 DOI: 10.3748/wjg.v24.i28.3071] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 63] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Choi YI, Jeong SH, Chung JW, Park DK, Kim KO, Kwon KA, Kim YJ, So S, Lee JH, Jeong JY, Lee SM. Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-Resistant H. pylori in Korea. Can J Infect Dis Med Microbiol. 2019;2019:9351801. [PMID: 31360270 DOI: 10.1155/2019/9351801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Noronha BP, Mambrini JVM, Torres KCL, Martins-Filho OA, Teixeira-Carvalho A, Lima-Costa MF, Peixoto SV. Chlamydia pneumoniae and Helicobacter pylori infections and immunological profile of community-dwelling older adults. Exp Gerontol 2021;156:111589. [PMID: 34637947 DOI: 10.1016/j.exger.2021.111589] [Reference Citation Analysis]
3 Matos R, Amorim I, Magalhães A, Haesebrouck F, Gärtner F, Reis CA. Adhesion of Helicobacter Species to the Human Gastric Mucosa: A Deep Look Into Glycans Role. Front Mol Biosci 2021;8:656439. [PMID: 34026832 DOI: 10.3389/fmolb.2021.656439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Raj R, Agarwal N, Raghavan S, Chakraborti T, Poluri KM, Pande G, Kumar D. Epigallocatechin Gallate with Potent Anti-Helicobacter pylori Activity Binds Efficiently to Its Histone-like DNA Binding Protein. ACS Omega 2021;6:3548-70. [PMID: 33585739 DOI: 10.1021/acsomega.0c04763] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Satuluri SH, Katari SK, Pasala C, Amineni U. Novel and potent inhibitors for dihydropteroate synthase of Helicobacter pylori. J Recept Signal Transduct Res 2020;40:246-56. [PMID: 32098568 DOI: 10.1080/10799893.2020.1731533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dardiotis E, Sokratous M, Tsouris Z, Siokas V, Mentis AA, Aloizou A, Michalopoulou A, Bogdanos DP, Xiromerisiou G, Deretzi G, Kountouras J, Hadjigeorgiou GM. Association between Helicobacter py lori infection and Guillain‐Barré Syndrome: A meta‐analysis. Eur J Clin Invest 2020;50. [DOI: 10.1111/eci.13218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ashida K, Honda Y, Sanada K, Takemura Y, Sakamoto S. The safety and effectiveness of vonoprazan-based Helicobacter pylori eradication therapy; a prospective post-marketing surveillance. Expert Opin Drug Saf 2019;18:1255-61. [PMID: 31646920 DOI: 10.1080/14740338.2019.1676722] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Hodeib MM, Ali AG, Kamel NM, Senosy SA, Fahmy EM, Abdelsadik A, Maebed MH. Impact of eradication therapy of Helicobacter pylori in children with chronic immune thrombocytopenic purpura. Egypt Pediatric Association Gaz 2021;69. [DOI: 10.1186/s43054-021-00053-3] [Reference Citation Analysis]
9 Maubach G, Lim MCC, Sokolova O, Backert S, Meyer TF, Naumann M. TIFA has dual functions in Helicobacter pylori-induced classical and alternative NF-κB pathways. EMBO Rep 2021;:e52878. [PMID: 34328245 DOI: 10.15252/embr.202152878] [Reference Citation Analysis]
10 Machate DJ, Figueiredo PS, Marcelino G, Guimarães RCA, Hiane PA, Bogo D, Pinheiro VAZ, Oliveira LCS, Pott A. Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis.Int J Mol Sci. 2020;21. [PMID: 32521778 DOI: 10.3390/ijms21114093] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
11 Sitkin S, Lazebnik L, Avalueva E, Kononova S, Vakhitov T. Gastrointestinal microbiome and Helicobacter pylori: Eradicate, leave it as it is, or take a personalized benefit–risk approach? World J Gastroenterol 2022; 28(7): 766-774 [DOI: 10.3748/wjg.v28.i7.766] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Fu P, Gao M, Yung KKL. Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis. ACS Chem Neurosci 2020;11:395-405. [PMID: 31876406 DOI: 10.1021/acschemneuro.9b00607] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 17.5] [Reference Citation Analysis]
13 Chen CY, Kao CL, Liu CM. The Cancer Prevention, Anti-Inflammatory and Anti-Oxidation of Bioactive Phytochemicals Targeting the TLR4 Signaling Pathway. Int J Mol Sci 2018;19:E2729. [PMID: 30213077 DOI: 10.3390/ijms19092729] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 16.5] [Reference Citation Analysis]
14 Rajilic-Stojanovic M, Figueiredo C, Smet A, Hansen R, Kupcinskas J, Rokkas T, Andersen L, Machado JC, Ianiro G, Gasbarrini A, Leja M, Gisbert JP, Hold GL. Systematic review: gastric microbiota in health and disease. Aliment Pharmacol Ther 2020;51:582-602. [PMID: 32056247 DOI: 10.1111/apt.15650] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 33.5] [Reference Citation Analysis]
15 Nabavi-rad A, Azizi M, Jamshidizadeh S, Sadeghi A, Aghdaei HA, Yadegar A, Zali MR, Niedźwiedzka-rystwej P. The Effects of Vitamins and Micronutrients on Helicobacter pylori Pathogenicity, Survival, and Eradication: A Crosstalk between Micronutrients and Immune System. Journal of Immunology Research 2022;2022:1-22. [DOI: 10.1155/2022/4713684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Park JM, Han YM, Oh JY, Lee DY, Choi SH, Kim SJ, Hahm KB. Fermented kimchi rejuvenated precancerous atrophic gastritis via mitigating Helicobacter pylori-associated endoplasmic reticulum and oxidative stress. J Clin Biochem Nutr 2021;69:158-70. [PMID: 34616108 DOI: 10.3164/jcbn.20-180] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Li Y, Lv T, He C, Wang H, Cram DS, Zhou L, Zhang J, Jiang W. Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin. Gut Pathog 2020;12:35. [PMID: 32670416 DOI: 10.1186/s13099-020-00373-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kasmi H, Doukani K, Ali A, Tabak S, Bouhenni H. Epidemiological Profile of Helicobacter pylori Infection in Patients with Digestive Symptoms in Algeria. J Epidemiol Glob Health 2020;10:293-7. [PMID: 32959615 DOI: 10.2991/jegh.k.200527.001] [Reference Citation Analysis]
19 Alipour M. Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer. J Gastrointest Cancer. 2021;52:23-30. [PMID: 32926335 DOI: 10.1007/s12029-020-00518-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
20 Requena T, Velasco M. The human microbiome in sickness and in health. Rev Clin Esp (Barc) 2021;221:233-40. [PMID: 33998505 DOI: 10.1016/j.rceng.2019.07.018] [Reference Citation Analysis]
21 Gottesmann M, Paraskevopoulou V, Mohammed A, Falcone FH, Hensel A. BabA and LPS inhibitors against Helicobacter pylori: pectins and pectin-like rhamnogalacturonans as adhesion blockers. Appl Microbiol Biotechnol 2020;104:351-63. [PMID: 31768613 DOI: 10.1007/s00253-019-10234-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
22 Peng C, Sang S, Shen X, Zhang W, Yan J, Chen P, Jiang C, Yuan Y, Zhu W, Yao M. In vitro anti-Helicobacter pylori activity of Syzygium aromaticum and the preliminary mechanism of action. J Ethnopharmacol 2022;:114995. [PMID: 35032584 DOI: 10.1016/j.jep.2022.114995] [Reference Citation Analysis]
23 González MF, Díaz P, Sandoval-Bórquez A, Herrera D, Quest AFG. Helicobacter pylori Outer Membrane Vesicles and Extracellular Vesicles from Helicobacter pylori-Infected Cells in Gastric Disease Development. Int J Mol Sci 2021;22:4823. [PMID: 34062919 DOI: 10.3390/ijms22094823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
24 Farahani NN, Kalani BS, Monavari SH, Mirkalantari S, Montazer F, Sholeh M, Javanmard Z, Irajian G. Therapeutic effects, immunogenicity and cytotoxicity of a cell penetrating peptide-peptide nucleic acid conjugate against cagA of Helicobacter pylori in cell culture and animal model. Iran J Microbiol 2021;13:360-71. [PMID: 34540175 DOI: 10.18502/ijm.v13i3.6399] [Reference Citation Analysis]
25 Hsieh YY, Tung SY, Pan HY, Chang TS, Wei KL, Chen WM, Deng YF, Lu CK, Lai YH, Wu CS, Li C. Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients. World J Gastroenterol 2021; 27(42): 7311-7323 [PMID: 34876791 DOI: 10.3748/wjg.v27.i42.7311] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
26 Öztekin M, Yılmaz B, Ağagündüz D, Capasso R. Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects. Diseases 2021;9:66. [PMID: 34698140 DOI: 10.3390/diseases9040066] [Reference Citation Analysis]
27 Pichon M, Freche B, Burucoa C. Guided Treatment of Helicobacter pylori Infections with Non-Invasive PCR Tests-The Glory Days of Primary Care? J Clin Med 2022;11:4320. [PMID: 35893411 DOI: 10.3390/jcm11154320] [Reference Citation Analysis]
28 Requena T, Velasco M. Microbioma humano en la salud y la enfermedad. Revista Clínica Española 2021;221:233-40. [DOI: 10.1016/j.rce.2019.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Bayraktar N, Güler İ, Bayraktar M, Koyuncu I. Investigation the levels of endotoxin and 8-hydroxy-2'-deoxyguanosine in sera of patients with Helicobacter pylori-positive peptic ulcer. Int J Clin Pract 2021;:e14501. [PMID: 34117680 DOI: 10.1111/ijcp.14501] [Reference Citation Analysis]
30 Peixoto SV, Torres KCL, Teixeira-Carvalho A, Martins-Filho OA, Lima-Costa MF. [Seroprevalence and factors associated with chronic infections among community-dwelling elderly individuals]. Cien Saude Colet 2021;26:5109-21. [PMID: 34787203 DOI: 10.1590/1413-812320212611.3.37062019] [Reference Citation Analysis]
31 Tubau-Juni N, Bassaganya-Riera J, Leber A, Zoccoli-Rodriguez V, Kronsteiner B, Viladomiu M, Abedi V, Philipson CW, Hontecillas R. Identification of new regulatory genes through expression pattern analysis of a global RNA-seq dataset from a Helicobacter pylori co-culture system. Sci Rep 2020;10:11506. [PMID: 32661418 DOI: 10.1038/s41598-020-68439-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Maev IV, Bakulin IG, Kurilovich SA, Bakulina NV, Andreev NG, Golubev NN. Helicobacter pylori and extragastroduodenal diseases: the proven facts and assumptions. Dok gastroenterol 2018;7:45. [DOI: 10.17116/dokgastro2018703145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Martin-Nuñez GM, Cornejo-Pareja I, Clemente-Postigo M, Tinahones FJ. Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders? Front Endocrinol (Lausanne) 2021;12:639856. [PMID: 34220702 DOI: 10.3389/fendo.2021.639856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Digifico E, Balinzo S, Belgiovine C. The Dark Side of the Force: When the Immune System Is the Fuel of Tumor Onset. Int J Mol Sci 2021;22:1224. [PMID: 33513730 DOI: 10.3390/ijms22031224] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Mohammadi A, Khanbabaei H, Zandi F, Ahmadi A, Haftcheshmeh SM, Johnston TP, Sahebkar A. Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105552] [Reference Citation Analysis]
36 Sohrabi A, Franzen J, Tertipis N, Zagai U, Li W, Zheng Z, Ye W. Efficacy of Loop-Mediated Isothermal Amplification for H. pylori Detection as Point-of-Care Testing by Noninvasive Sampling. Diagnostics (Basel) 2021;11:1538. [PMID: 34573879 DOI: 10.3390/diagnostics11091538] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Zorgetto-Pinheiro VA, Machate DJ, Figueiredo PS, Marcelino G, Hiane PA, Pott A, Guimarães RCA, Bogo D. Omega-3 Fatty Acids and Balanced Gut Microbiota on Chronic Inflammatory Diseases: A Close Look at Ulcerative Colitis and Rheumatoid Arthritis Pathogenesis. J Med Food 2022;25:341-54. [PMID: 35438557 DOI: 10.1089/jmf.2021.0012] [Reference Citation Analysis]
38 Choi YI, Chung JW, Park DK, Kim KO, Kwon KA, Kim YJ, Seo JY. Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial. World J Gastroenterol 2019; 25(46): 6743-6751 [PMID: 31857776 DOI: 10.3748/wjg.v25.i46.6743] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
39 Gonciarz W, Lechowicz Ł, Urbaniak M, Kaca W, Chmiela M. Use of Fourier-Transform Infrared Spectroscopy (FT-IR) for Monitoring Experimental Helicobacter pylori Infection and Related Inflammatory Response in Guinea Pig Model. Int J Mol Sci 2020;22:E281. [PMID: 33396581 DOI: 10.3390/ijms22010281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Zheng W, Zhu Z, Ying J, Long G, Chen B, Peng K, Li F, Zhao H, Jiang M. The Effects of Helicobacter pylori Infection on Gastric Microbiota in Children With Duodenal Ulcer. Front Microbiol 2022;13:853184. [PMID: 35547124 DOI: 10.3389/fmicb.2022.853184] [Reference Citation Analysis]
41 Wu SE, Chen WL. Detrimental relevance of Helicobacter pylori infection with sarcopenia. Gut Pathog 2021;13:67. [PMID: 34782007 DOI: 10.1186/s13099-021-00464-y] [Reference Citation Analysis]
42 Filardo S, Scalese G, Virili C, Pontone S, Di Pietro M, Covelli A, Bedetti G, Marinelli P, Bruno G, Stramazzo I, Centanni M, Sessa R, Severi C. The Potential Role of Hypochlorhydria in the Development of Duodenal Dysbiosis: A Preliminary Report. Front Cell Infect Microbiol 2022;12:854904. [DOI: 10.3389/fcimb.2022.854904] [Reference Citation Analysis]
43 Maubach G, Vieth M, Boccellato F, Naumann M. Helicobacter pylori-induced NF-κB: trailblazer for gastric pathophysiology. Trends Mol Med 2022:S1471-4914(21)00322-1. [PMID: 35012886 DOI: 10.1016/j.molmed.2021.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Choi HG, Soh JS, Lim JS, Sim SY, Jung YJ, Lee SW. Peptic ulcer does not increase the risk of dementia: A nested case control study using a national sample cohort. Medicine (Baltimore) 2020;99:e21703. [PMID: 32872044 DOI: 10.1097/MD.0000000000021703] [Reference Citation Analysis]
45 Tao F, Xing X, Wu J, Jiang R. Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice. PLoS One 2021;16:e0248482. [PMID: 33764993 DOI: 10.1371/journal.pone.0248482] [Reference Citation Analysis]
46 Merlotti D, Mingiano C, Valenti R, Cavati G, Calabrese M, Pirrotta F, Bianciardi S, Palazzuoli A, Gennari L. Bone Fragility in Gastrointestinal Disorders. Int J Mol Sci 2022;23:2713. [PMID: 35269854 DOI: 10.3390/ijms23052713] [Reference Citation Analysis]
47 Suárez-Jaramillo A, Baldeón ME, Prado B, Fornasini M, Cohen H, Flores N, Salvador I, Cargua O, Realpe J, Cárdenas PA. Duodenal microbiome in patients with or without Helicobacter pylori infection. Helicobacter 2020;25:e12753. [PMID: 32896972 DOI: 10.1111/hel.12753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Farina M, Brundu A, Bonferoni MC, Juliano C, Rassu G, Gavini E, Cerri G. Antibacterial activity of Na-clinoptilolite against Helicobacter pylori: in-vitro tests, synergistic effect with amoxicillin and stability of the antibiotic formulated with the zeolite. Microporous and Mesoporous Materials 2019;288:109592. [DOI: 10.1016/j.micromeso.2019.109592] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
49 Mărginean CO, Meliț LE, Săsăran MO. Gastric Microenvironment-A Partnership between Innate Immunity and Gastric Microbiota Tricks Helicobacter pylori. J Clin Med 2021;10:3258. [PMID: 34362042 DOI: 10.3390/jcm10153258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
50 Liu XZ, Zhang YM, Jia NY, Zhang H. Helicobacter pylori infection is associated with elevated galactose-deficient IgA1 in IgA nephropathy. Ren Fail 2020;42:539-46. [PMID: 32524871 DOI: 10.1080/0886022X.2020.1772295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Park JM, Han YM, Park YJ, Hahm KB. Dietary intake of walnut prevented Helicobacter pylori-associated gastric cancer through rejuvenation of chronic atrophic gastritis. J Clin Biochem Nutr 2021;68:37-50. [PMID: 33536711 DOI: 10.3164/jcbn.20-103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Wu L, Jiang F, Shen X. Helicobacter pylori CagA Protein Regulating the Biological Characteristics of Gastric Cancer through the miR-155-5p/SMAD2/SP1 axis. Pathogens 2022;11:846. [DOI: 10.3390/pathogens11080846] [Reference Citation Analysis]
53 Baj J, Forma A, Sitarz M, Portincasa P, Garruti G, Krasowska D, Maciejewski R. Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment. Cells 2020;10:E27. [PMID: 33375694 DOI: 10.3390/cells10010027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
54 Choi HG, Rhim CC, Yoon JY, Park BJ, Min CY, Lee SW. Increased risk of osteoporosis in patients with peptic ulcer: a follow-up study using a national sample cohort. Arch Osteoporos 2019;14. [DOI: 10.1007/s11657-019-0659-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Keikha M, Eslami M, Yousefi B, Ghasemian A, Karbalaei M. Potential antigen candidates for subunit vaccine development against Helicobacter pylori infection. J Cell Physiol 2019;234:21460-70. [DOI: 10.1002/jcp.28870] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
56 Dash NR, Khoder G, Nada AM, Al Bataineh MT. Exploring the impact of Helicobacter pylori on gut microbiome composition.PLoS One. 2019;14:e0218274. [PMID: 31211818 DOI: 10.1371/journal.pone.0218274] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
57 Gennari L, Merlotti D, Figura N, Mingiano C, Franci MB, Lucani B, Picchioni T, Alessandri M, Campagna MS, Gonnelli S, Bianciardi S, Materozzi M, Caffarelli C, Gonnelli S, Nuti R. Infection by CagA-Positive Helicobacter pylori Strains and Bone Fragility: A Prospective Cohort Study. J Bone Miner Res 2021;36:80-9. [PMID: 32790186 DOI: 10.1002/jbmr.4162] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
58 Conti L, Annibale B, Lahner E. Autoimmune Gastritis and Gastric Microbiota. Microorganisms 2020;8:E1827. [PMID: 33228138 DOI: 10.3390/microorganisms8111827] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
59 Kashyap D, Baral B, Verma TP, Sonkar C, Chatterji D, Jain AK, Jha HC. Oral rinses in growth inhibition and treatment of Helicobacter pylori infection. BMC Microbiol 2020;20:45. [PMID: 32131741 DOI: 10.1186/s12866-020-01728-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Fallah S, Marsche G, Mohamadinarab M, Mohassel Azadi S, Ghasri H, Fadaei R, Moradi N. Impaired cholesterol efflux capacity in patients with Helicobacter pylori infection and its relation with inflammation. J Clin Lipidol 2021;15:218-226.e1. [PMID: 33250430 DOI: 10.1016/j.jacl.2020.11.005] [Reference Citation Analysis]
61 Krupa A, Gonciarz W, Rusek-Wala P, Rechciński T, Gajewski A, Samsel Z, Dziuba A, Śmiech A, Chmiela M. Helicobacter pylori Infection Acts Synergistically with a High-Fat Diet in the Development of a Proinflammatory and Potentially Proatherogenic Endothelial Cell Environment in an Experimental Model. Int J Mol Sci 2021;22:3394. [PMID: 33806236 DOI: 10.3390/ijms22073394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Tsimpiris A, Grigoriadis A, Tsolianos I, Moschos I, Goulis DG, Kouklakis G. Periodontitis and Helicobacter pylori Infection: Eradication and Periodontal Therapy Combination. Eur J Dent 2021. [PMID: 34598295 DOI: 10.1055/s-0041-1731928] [Reference Citation Analysis]
63 Fisher L, Fisher A, Smith PN. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). J Clin Med 2020;9:E3253. [PMID: 33053671 DOI: 10.3390/jcm9103253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Gong Y, Chen S, Fu Y, Liu Y, Wang Y, Yang H, Liu H, Tang L. MUC4 is a novel mediator in H. pylori infection-related pancreatic cancer. Oncol Lett 2021;21:123. [PMID: 33552244 DOI: 10.3892/ol.2020.12384] [Reference Citation Analysis]